GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » JW Pharmaceutical (XKRX:001060) » Definitions » Short-Term Capital Lease Obligation

JW Pharmaceutical (XKRX:001060) Short-Term Capital Lease Obligation : ₩4,401 Mil (As of Sep. 2024)


View and export this data going back to 1976. Start your Free Trial

What is JW Pharmaceutical Short-Term Capital Lease Obligation?

JW Pharmaceutical's Short-Term Capital Lease Obligation for the quarter that ended in Sep. 2024 was ₩4,401 Mil.

JW Pharmaceutical's quarterly Short-Term Capital Lease Obligation increased from Mar. 2024 (₩4,367 Mil) to Jun. 2024 (₩4,522 Mil) but then declined from Jun. 2024 (₩4,522 Mil) to Sep. 2024 (₩4,401 Mil).

JW Pharmaceutical's annual Short-Term Capital Lease Obligation declined from Dec. 2021 (₩1,274 Mil) to Dec. 2022 (₩1,253 Mil) but then increased from Dec. 2022 (₩1,253 Mil) to Dec. 2023 (₩4,270 Mil).

JW Pharmaceutical Short-Term Capital Lease Obligation Historical Data

The historical data trend for JW Pharmaceutical's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

JW Pharmaceutical Short-Term Capital Lease Obligation Chart

JW Pharmaceutical Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Short-Term Capital Lease Obligation
Get a 7-Day Free Trial Premium Member Only Premium Member Only 928.32 849.50 1,274.39 1,253.28 4,270.45

JW Pharmaceutical Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Short-Term Capital Lease Obligation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4,366.32 4,270.45 4,367.14 4,522.03 4,401.19

JW Pharmaceutical Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

JW Pharmaceutical Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of JW Pharmaceutical's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

JW Pharmaceutical Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » JW Pharmaceutical (XKRX:001060) » Definitions » Short-Term Capital Lease Obligation
Comparable Companies
XKRX:003850 XKRX:019170 XKRX:000640 XKRX:003090 XKRX:086450 XKRX:243070 XKRX:170900 XKRX:249420 XKRX:003000 XKRX:003520 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
001067:Korea 001065.PFD:Korea
Address
2477, Nambusunhwan-ro, Seocho-gu, KOR
Website
https://www.jw-pharma.co.kr
JW Pharmaceutical is active in the healthcare sector. It has been one of the leading companies in the pharmaceutical market on a global basis. Its original medicine and medical supply pipeline include Livalo, Thrupas, Sigmart and Actemra. It also develops low-protein and low-salt diet food for patients suffering from chronic renal insufficiency as well as general Pharmaceuticals and health care products.

JW Pharmaceutical Headlines

No Headlines